Saturday, March 11, 2017 11:12:00 AM
A/D is supposed to be accumulation and distribution - but it really isn't because it is heavily affected by shorting and wash trading. IMO that second wave down was an attempt to keep the stock down and discourage buying. It occurred at the same time as sector wide move, it affected the valuations of all of my holdings that I expect returns on in the next few months. My interpretation of the move was it was a last ditch efforts by shorts to cover before a biotech bull market.
FTR is a better indication of accumulation and it was bullish around 3/2 and now neutral. MACD is positive, stock is still showing oversold. I don't like the OBV or the ADX still. I don't think you can get a sustainable reversal without those two indicators showing improvement.
Interestingly enough the stock almost hit the "golden cross" 50/200 sma crossover before it dived.
Now I have to move to the 360 minute chart. This is another way of getting rid of end of day paints.
After the initial crash we are seeing more green volume candles than red ones, also a good sign. FTR is snaking up, that is bullish. MACD is green, RSI is improving. That negative bubble in the OBV after 3/7 could be due to manipulative shorting due to the sector move, note that it was improving before that. ADX is narrowing that is a good sign.
Looking at this I would expect the stock to spike with a bullish market (which may come next week or be held to after options expiration on the 17th).
Speaking of options - you have to consider them too. I very much doubt that the stock will be allowed to go over $5 before the 17th. Too much is riding on the options, which are usually...but not always, held by retail.
Recent TRVN News
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 10:00:24 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 02/20/2024 09:06:01 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 07:34:30 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 02/09/2024 09:05:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 12:05:28 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/23/2024 09:15:32 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 01/23/2024 05:15:19 AM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 01/19/2024 09:30:30 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 01/10/2024 09:30:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 12:01:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/28/2023 07:09:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 11:57:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 11:57:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 11:57:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 11:56:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 11:56:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/05/2023 10:51:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/05/2023 10:50:51 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/05/2023 10:50:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/05/2023 10:49:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/05/2023 10:47:39 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 12/01/2023 10:12:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 10:21:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/02/2023 11:05:20 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/18/2023 09:26:45 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM